+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Somatostatin"

Zollinger-Ellison Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Zollinger-Ellison Syndrome Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Acromegaly Market Report 2025 - Product Thumbnail Image

Acromegaly Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Somatostatin Analogs Market Report 2025 - Product Thumbnail Image

Somatostatin Analogs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report 2025 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Octreotide Global Market Report 2025 - Product Thumbnail Image

Octreotide Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Neuroendocrine Carcinoma Global Market Report 2025 - Product Thumbnail Image

Neuroendocrine Carcinoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Acromegaly Treatment - Global Strategic Business Report - Product Thumbnail Image

Acromegaly Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 297 Pages
  • Global
From
From
Insulinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Insulinoma Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 250 Pages
  • Global
From
Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • August 2025
  • 280 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Acromegaly- Pipeline Insight, 2025 - Product Thumbnail Image

Acromegaly- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
Loading Indicator

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer. Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production. Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more